STOCK TITAN

SI-BONE (NASDAQ: SIBN) CEO sells shares in tax-cover trades

(High)
(Negative)
Form Type
4

Rhea-AI Filing Summary

SI-BONE, Inc. (SIBN) disclosed that Chief Executive Officer Laura Francis reported multiple same‑day open‑market sales totaling 14,956 shares of common stock on 2026-08-17 at weighted average prices around $18.63–$18.68 per share. Footnotes state these were "sell to cover" transactions executed to satisfy tax withholding obligations upon the vesting of restricted stock units and are not discretionary trades. After these trades, 373,270 shares are held indirectly by The David & Laura Joint Rev Tr., and an additional 355,697 shares are issuable upon settlement of restricted stock units granted to the reporting person.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider FRANCIS LAURA
Role Chief Executive Officer
Sold 14,956 shs ($279K)
Type Security Shares Price Value
Sale Common Stock F1, F2 3,892 $18.6578 $73K
Sale Common Stock F1, F2 3,652 $18.6595 $68K
Sale Common Stock F1, F2 3,203 $18.663 $60K
Sale Common Stock F1, F3 2,236 $18.6814 $42K
Sale Common Stock F1, F4, F5, F6 1,973 $18.6289 $37K
holding Common Stock F7 -- -- --
Holdings After Transaction: Common Stock — 493,900 shares (Direct); Common Stock — 373,270 shares (Indirect, by Trust)
Footnotes (7)
  1. F1. The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
  2. F2. This transaction was executed in multiple trades at prices ranging from $18.52 USD to $18.77 USD; the price reported above reflects the weighted average sale price.
  3. F3. This transaction was executed in multiple trades at prices ranging from $18.52 USD to $18.79 USD; the price reported above reflects the weighted average sale price.
  4. F4. This transaction was executed in multiple trades at prices ranging from $18.55 USD to $18.73 USD; the price reported above reflects the weighted average sale price.
  5. F5. Includes 355,697 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  6. F6. Reflects the transfer of shares from the Reporting Person to The David & Laura Joint Rev Tr.
  7. F7. Shares held by The David & Laura Joint Rev Tr.
Total shares sold 14,956 shares Aggregate common shares sold by CEO Laura Francis on 2026-08-17
Sale price (example transaction) $18.6578 per share Weighted average sale price for 3,892 shares of common stock sold on 2026-08-17
Sale price range (trade group F2) $18.52–$18.77 Price range for grouped trades where the reported price is a weighted average sale price
Sale price range (trade group F3) $18.52–$18.79 Price range for another group of trades with weighted average sale price reported
Trust-held shares 373,270 shares Common shares held indirectly by The David & Laura Joint Rev Tr.
RSU-related shares issuable 355,697 shares Shares issuable upon settlement of restricted stock units granted to the reporting person
sell to cover financial
"The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction"
Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.
restricted stock units financial
"Includes 355,697 shares issuable on the settlement of restricted stock units granted"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
weighted average sale price financial
"the price reported above reflects the weighted average sale price"
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share"

FAQ

What insider transaction did SI-BONE (SIBN) report for CEO Laura Francis?

SI-BONE reported that CEO Laura Francis sold 14,956 shares of common stock on 2026-08-17. The sales were conducted as part of a sell to cover arrangement to satisfy tax withholding obligations tied to vesting restricted stock units, and not as discretionary trades.

At what prices were the SIBN shares sold by CEO Laura Francis on 2026-08-17?

The reported sales occurred at weighted average prices between about $18.63 and $18.68 per share. Footnotes specify execution in multiple trades within ranges such as $18.52–$18.79, with the per‑row prices reflecting the weighted average sale price for those grouped trades.

Were the August 17, 2026 SIBN share sales by CEO Laura Francis discretionary?

No. A footnote explains the sale represents shares required to be sold to cover tax withholding obligations on vesting restricted stock units. It clarifies the transactions are part of a “sell to cover” tax arrangement and do not represent a discretionary trade by the CEO.

How many SI-BONE (SIBN) shares are held through The David & Laura Joint Rev Tr?

The filing states that 373,270 shares of SI-BONE common stock are held by The David & Laura Joint Rev Tr. A separate footnote notes these shares are held by that trust, indicating indirect ownership by the reporting person through this entity.

What restricted stock unit position does SI-BONE (SIBN) report for CEO Laura Francis?

A footnote states that the position includes 355,697 shares issuable upon settlement of restricted stock units granted to the reporting person. Each restricted stock unit represents a contingent right to receive one share of SI-BONE’s common stock upon settlement.

How many total SIBN shares did CEO Laura Francis sell in this Form 4 filing?

Across five reported sale transactions, CEO Laura Francis sold a total of 14,956 shares of SI-BONE common stock. These sales were all dated 2026-08-17 and are described as open‑market or private transactions used to cover tax withholding on RSU vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
FRANCIS LAURA

(Last)(First)(Middle)
C/O SI-BONE, INC.
471 EL CAMINO REAL, SUITE 101

(Street)
SANTA CLARA CALIFORNIA 95050

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
SI-BONE, Inc. [ SIBN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/17/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/17/2026S(1)3,892D$18.6578(2)499,552D
Common Stock08/17/2026S(1)3,652D$18.6595(2)495,900D
Common Stock08/17/2026S(1)3,203D$18.663(2)492,697D
Common Stock08/17/2026S(1)2,236D$18.6814(3)490,461D
Common Stock08/17/2026S(1)1,973D$18.6289(4)493,900(5)(6)D
Common Stock373,270Iby Trust(7)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
2. This transaction was executed in multiple trades at prices ranging from $18.52 USD to $18.77 USD; the price reported above reflects the weighted average sale price.
3. This transaction was executed in multiple trades at prices ranging from $18.52 USD to $18.79 USD; the price reported above reflects the weighted average sale price.
4. This transaction was executed in multiple trades at prices ranging from $18.55 USD to $18.73 USD; the price reported above reflects the weighted average sale price.
5. Includes 355,697 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
6. Reflects the transfer of shares from the Reporting Person to The David & Laura Joint Rev Tr.
7. Shares held by The David & Laura Joint Rev Tr.
Remarks:
/s/ Michael A. Pisetsky, Attorney-in-Fact for Laura A. Francis08/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)